Using computer-aided detection software to help find target areas in images may result in readers missing areas not marked for viewing.
Using computer-aided detection (CAD) software to help find target areas in images may actually result in readers missing areas not marked for viewing, according to research published in the October issue of Academic Radiology.
Researchers performed two experiments as part of an eye-tracking study to determine eye movements as images were being read. Forty-seven observers with an average age of 24.3 years examined images for the targets, which were the letter “T.” Throughout the image, there were also several marks of the letter “L.”
The first experiment provided high noise and low similarity between the targets, meant to cause distraction and making the targets more difficult to locate. The second experiment used less distraction and provided more targets, making the targets easier to find.
Researchers found that although in the first experiment, observers were able to find many of the targets, guided by the CAD, this came at a cost: If targets were not in an area marked by the CAD, they were likely not located. For the second experiment, there was no noted behavioral benefit from CAD, but neither was there a cost in missed targets as there was in the first experiment.
In evaluating eye movements, the researchers saw that the CAD observers looked at a lower total area than did the non-CAD observers.
“CAD signals do not combine with observers' unaided performance in a straightforward manner,” concluded the authors. “CAD can engender a sense of certainty that can lead to incomplete search and elevated chances of missing unmarked stimuli.”
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.